Product Program year 2024 Source: CMS Open Payments

Nidra

Device Restless Leg Syndrome

Open in the dashboard

General payments

$30,661

124 payments

Research payments

$87,922

18 payments

Through program year 2024, $30,661 in general payments and $87,922 in research payments were reported against Nidra (Restless Leg Syndrome).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2024 General $30,661 124
2024 Research $87,922 18

Breakdown

Who paid General payments · program year 2024
  1. Noctrix Health, Inc. $30,661 124 payments
Top recipients General payments · program year 2024
  1. Haramandeep Singh Sleep Medicine · San Ramon, CA $20,400 67% · 7 payments
  2. Brenda Latowsky Procedural Dermatology · Scottsdale, AZ $596 2% · 2 payments
  3. Christen Cheuvront Nurse Practitioner, Family · Alliance, OH $420 1% · 3 payments
  4. Margaret Heidenreich Nurse Practitioner, Gerontology · Chantilly, VA $420 1% · 3 payments
  5. Maureen Lally Nurse Practitioner, Family · Middleburg Heights, OH $288 <1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Sleep Medicine Psychiatry & Neurology $20,985 69% · 8 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $1,614 5% · 12 practitioners
  3. Neurology Psychiatry & Neurology $1,484 5% · 18 practitioners
  4. Sleep Medicine Internal Medicine $996 3% · 12 practitioners
  5. Nurse Practitioner $948 3% · 9 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $23,314 76% · 34 recipients
  2. Ohio $2,225 7% · 14 recipients
  3. North Carolina $829 3% · 11 recipients
  4. Arizona $596 2% · 1 recipient
  5. Michigan $593 2% · 8 recipients

The top 5 of 21 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

124 general · 18 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record